{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey to understand the perception and practice of urologists in management of lower urinary tract symptoms (LUTS)

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif
  1. Age (years) *

  2. Degree/Qualification*
  3. Place of Practice *

  4. Clinical experience in managing patients with BPH due to LUTS *

  5. Number of patients suffering from LUTS treated per month *

    6. Screening of BPH
  6. Which of the following is the most common storage symptom associated with your BPH patients? *

    7. (Note: The total percentage can exceed 100% as patient may experience multiple symptoms)

    (A) Storage symptoms Please tick the most common symptom
    Daytime frequency

    Nocturia

    Urgency

    Urgency incontinence

    (B) Storage symptoms % prevalence of below all symptoms
    Daytime frequency
    %
    Nocturia
    %
    Urgency
    %
    Urgency incontinence
    %
  7. Which of the following is the most common voiding symptom associated with your BPH patients? *
    8. (A) Voiding symptoms Please tick the most common symptom
    Hesitancy

    Intermittency

    Slow stream

    Splitting or spraying of the stream

    Straining

    Terminal dribble

    (B) Voiding symptoms % prevalence of below all symptoms
    Hesitancy
    %
    Intermittency
    %
    Slow stream
    %
    Splitting or spraying of the stream
    %
    Straining
    %
    Terminal dribble
    %
  8. What methods do you use for initial screening of BPH? (Select all that apply) *

    9. Diagnostic tests
  9. Which diagnostic tests do you typically use to confirm a diagnosis of BPH? (Select all that apply) *

    10. Treatment of BPH
  10. Do you advise watchful waiting for patients with BPH with non-bothersome mild to moderate symptoms? *

  11. Which of the following non-pharmacological approaches do you use in the management of patients with BPH? (Select all that apply) *

  12. When selecting an appropriate alpha blocker for a patient with BPH, which factors do you consider, in order of priority? Please rank the following factors as 1 (most important), 2 (moderately important) and 3 (least important) *
    13. Age of the patient
    Associated comorbidities (e.g., diabetes, heart disease)
    Dominance of voiding symptoms over storage symptoms or vice
    Prostate volume
    Sexual activeness
    Severity of symptoms
    Side effect profile of drug
    Concomitant erectile dysfunction
  13. What initial treatment options do you typically recommend for patients with mild to moderate BPH symptoms? (Please select the most preferred drug) *
    14. Drug Prostate volume <30 cc Prostate volume >30 cc
    Alpha blockers

    Combination therapy (alpha-blocker + 5ARI)

    Phosphodiesterase type 5 inhibitor monotherapy [PDE5 inhibitor]

    Combination therapy (alpha-blocker + Tadalafil)

    Phytotherapy

  14. Which alpha blocker or combination do you prescribe for mild to moderate bothersome LUTS? *

    15. Please indicate how many out of 10 patients you prescribe each medication to

    Medication Mention number out of 10 patients
    Silodosin/ combination with 5ARI
    Tamsulosin/ combination with 5ARI
    Alfuzosin/ combination with 5ARI
    Tadalafil/ combination with alpha blocker
  15. Select your preferred alpha blocker or its combination from above list for below mentioned clinical scenario or mention any other choice *
    16. BPH patient with cardiovascular comorbidity
    BPH patient with erectile dysfunction
    Sexually active patient with BPH
    40-50 years old BPH patient
    50-60 years old BPH patient
    > 60 years old BPH patient
    BPH patient with predominant bothersome nocturia
    BPH patient with IPSS score 0-7
    BPH patient with IPSS score 8-19
    BPH patient with IPSS score 20-35
  16. In your opinion, what are the advantages of Silodosin over other alpha blockers? (Select all that apply) *

  17. Please suggest strategies or best practices when using alpha blockers to optimize treatment outcomes in BPH patients. *
  18. When do you consider a patient with BPH for surgery? (Select all that apply) *

  19. When deciding an appropriate surgical option for a patient with BPH, which factors do you consider, in order of priority? Please rank the following factors from 1 (most important) to 7 (least important) *
    20. Size and shape of prostate gland
    Patient’s bleeding risk
    Symptom severity
    Presentation (e.g.; concurrent stone)
    Patient’s attitude towards potential sexual side effect
    Personal preference
    Economic status of patient
  20. Which among the following surgical option do you prefer for treating BPH in following scenario? *

    21. 1. Transurethral resection of the Prostate (TURP)
    2. Simple Prostatectomy (Open or laparoscopic)
    3. Robotic assisted prostatectomy
    4. Transurethral Incision of the Prostate (TUIP)
    5. Transurethral Vaporization of the Prostate (TUVP)
    6. Photoselective Vaporization of the Prostate (PVP)
    7. Prostatic Urethral Lift (PUL)
    8. Water Vapor Thermal Therapy (WVTT)
    9. Laser Enucleation (e.g., HoLEP, ThuLEP)
    10. Prostate Artery Embolization (PAE)
    11. Temporary Implanted Prostatic Devices (TIPD)

    Scenario Select the number from above mentioned list for preferred choice
    Prostate size ≤ 30 grams
    Prostate size 30-80 grams
    Prostate size > 80 grams
    Patients on anticoagulation or antiplatelet medications
    Patient desiring to preserve erectile and ejaculatory functions
    Economic status of patient
    Challenges in managing BPH
  21. What are the main challenges you face while managing BPH patients? *
  22. Are you satisfied with the current level of public awareness about BPH or prostate related disease? *

  23. How can we improve patient education and awareness about BPH (Select all that apply) *

  24. In your opinion, when should patients with BPH be referred to you by a primary care physician? *
  25. How do you currently update your knowledge related to management of urological disorders? (Select all that apply) *